Benzinga | Jan 26, 2022 05:02AM EST

Deutsche Bank Upgrades Moderna to Hold, Announces $175 Price Target

Deutsche Bank analyst Emmanuel Papadakis upgrades Moderna (NASDAQ:MRNA) from Sell to Hold and announces $175 price target.